콘텐츠로 건너뛰기
  • SOLUTIONS
    • Drug Discovery Sevices
    • Collaboration Partners
    • Platform
  • R&D
    • Platform Technology
    • Pipelines
    • Publications
    • Patent & Cert.
  • ABOUT US
    • Overview
    • History
    • Partnership
    • CI & BI
  • NEWS
    • Press Release
    • Seminars & Events
    • Notice
    • Responsibility
  • CAREER
Menu
  • SOLUTIONS
    • Drug Discovery Sevices
    • Collaboration Partners
    • Platform
  • R&D
    • Platform Technology
    • Pipelines
    • Publications
    • Patent & Cert.
  • ABOUT US
    • Overview
    • History
    • Partnership
    • CI & BI
  • NEWS
    • Press Release
    • Seminars & Events
    • Notice
    • Responsibility
  • CAREER
Get In Touch

Press Release

HOME > NEWS > Press Release​

Korean startups using AI in drug discovery; Especially clinical trial success using AI at PharmCADD.

READ MORE

PharmCADD has been certified ‘Intellectual Property Management Enterprise’ from the Korean Intellectual Property Office.

READ MORE

PharmCADD showed proprietary AI technology at Medicine-Bio Forum 2022.

READ MORE

PharmCADD was selected into the KOREA AI STARTUP 100 list.

READ MORE

PharmCADD participated in AI KOREA 2022.

READ MORE

“AI” will accellerate the drug developement.

READ MORE

PharmCADD won “2022 AI KOREA Awards” from The Ministry of Trade, Industry and Energy.

READ MORE

PharmCADD & ISU ABXIS jointly develop a medicine for the treatment of neurofibromatosis type 1 (NFI)

READ MORE

“Break the New Drug development limits through AI based on Quantum Mechanics.”

READ MORE
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Next »
Headquarters

Address : 224, Engineering Building 7, Sinseon-Ro 365, Namgu, Busan 48548, Republic of Korea
Call : 82-51-747-5681 | Fax : 82-51-747-5682

Seoul Office

Address : 1735, 280, Gwangpyeong-ro, Gangnam-gu, Seoul, Republic of Korea
Call : 82-2-564-5688 | Fax : 82-2-564-5685

E-Mail : [email protected]
Call : 82-51-747-5681
Linkedin-in Youtube

© 2021 PharmCADD. All Rights Reserved.